The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma

David J. Sher, John W. Henson, Bindu Avutu, Fred H. Hochberg, Tracy T. Batchelor, Robert L. Martuza, Fred G. Barker, Jay S. Loeffler, Arnab Chakravarti

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint Dive into the research topics of 'The added value of concurrently administered temozolomide versus adjuvant temozolomide alone in newly diagnosed glioblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences